UnitedHealth price target raised to $617 from $615 at Deutsche Bank

Deutsche Bank analyst George Hill raised the firm’s price target on UnitedHealth to $617 from $615 and keeps a Buy rating on the shares post the Q4 results. Despite uncertainties in Medicare and Medicaid on the policy front and in commercial due to the economic pressure, UnitedHealth is "prudent in the guidance and has multiple levers to pull to deliver upside," the analyst tells investors in a research note.